Akums Drugs and Pharmaceuticals - Share Price & Details
2 Week Avg Qty
0.23(Lakh)
Circuit Limit
6,541.00/430.90
High price all time
1,176
Broker Recommendations
| Date |
Author |
Type |
Reco Price |
Target Price |
Potential |
Source |
PDF Link |
| 17 Feb 2026 |
ICICI Securities |
Buy |
₹476.4 |
₹680 |
38.7% |
moneycontrol |
View |
| 22 Dec 2025 |
ICICI Securities |
Buy |
₹443.7 |
₹600 |
32.6% |
moneycontrol |
View |
| 15 Nov 2025 |
ICICI Securities |
Buy |
₹424.4 |
₹565 |
31.3% |
moneycontrol |
View |
| 17 Mar 2025 |
ICICI Securities |
Buy |
₹507.55 |
₹710 |
36.9% |
moneycontrol |
View |
| 09 Feb 2025 |
ICICI Securities |
Buy |
₹560.05 |
₹710 |
31% |
moneycontrol |
View |
Peer Comparison
About Akums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceutical has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
Quarterly Table
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|
| Sales | 317.3 | 328.3 | 337.4 | 328.8 |
|---|
| Expenses | 273.6 | 285.3 | 303.4 | 311.0 |
|---|
| Operating Profit | 43.7 | 43.1 | 34.0 | 17.8 |
|---|
| OPM % | 13.77% | 13.12% | 10.08% | 5.41% |
|---|
| Other Income | 26.2 | 32.1 | 33.8 | 32.1 |
|---|
| Interest | 6.2 | 4.2 | 2.3 | 2.6 |
|---|
| Depreciation | 9.4 | 9.4 | 10.7 | 10.1 |
|---|
| Profit before tax | 54.3 | 61.6 | 54.9 | 37.1 |
|---|
| Tax % | 22.8% | -18.3% | 25% | -25.4% |
|---|
| Net Profit | 41.9 | 50.4 | 41.2 | 27.6 |
|---|
| EPS in Rs | 2.93 | 3.38 | 2.69 | 0 |
|---|
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 |
|---|
| Sales | 1,019.1 | 1,033.1 | 1,010.4 | 1,055.5 | 1,024.0 | 1,017.5 | 1,159.6 | 1,159.6 |
|---|
| Expenses | 891.1 | 911.9 | 889.0 | 961.6 | 895.1 | 923.1 | 1,012.7 | 1,012.7 |
|---|
| Operating Profit | 128.0 | 121.2 | 121.4 | 94.0 | 129.0 | 94.5 | 146.9 | 146.9 |
|---|
| OPM % | 12.56% | 11.73% | 12.01% | 8.9% | 12.59% | 9.28% | 12.66% | 12.66% |
|---|
| Other Income | 6.5 | 17.2 | 19.3 | 25.8 | 26.7 | 32.4 | 16.1 | 16.1 |
|---|
| Interest | 13.0 | 11.9 | 5.1 | 4.5 | 23.1 | 23.3 | 23.7 | 23.7 |
|---|
| Depreciation | 34.1 | 34.9 | 44.5 | 40.0 | 36.9 | 37.9 | 39.6 | 39.6 |
|---|
| Profit before tax | 87.5 | 87.9 | 86.3 | 67.0 | 95.6 | 65.7 | 117.8 | 117.8 |
|---|
| Tax % | -30% | 27.2% | -27.2% | 99% | 32.4% | 35% | 32% | 32% |
|---|
| Net Profit | 61.2 | 66.7 | 66.3 | 149.6 | 64.7 | 42.7 | 67.7 | 67.7 |
|---|
| EPS in Rs | 4.21 | 4.37 | 4.26 | 0 | 4.15 | 2.66 | 4.33 | 4.33 |
|---|
Shareholding Distribution
Shareholding Pattern
Compounded Data
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
16% |
| 3 Years: |
20% |
| TTM: |
12% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| TTM: |
-168% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
15% |
| TTM: |
14% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| TTM: |
-120% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
